Androgen Deprivation Therapy Global Market Report 2025
상품코드:1810824
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
안드로겐 제거 요법 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR) 6.0%로 104억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 암 치료에서 병용요법의 사용 확대, 호르몬 민감성 암 환자 수 증가, 국소 전립선암 및 진행성 전립선암 진단 증가, 암 이외의 호르몬 질환에 대한 ADT의 광범위한 적용, 비침습적 치료에 대한 환자 선호도 증가로 인해 발생할 것으로 예상됩니다. 비침습적 치료에 대한 환자들의 선호도 증가로 인한 것입니다. 이 기간 동안 주요 동향으로는 디포 제형 및 전달 시스템의 개선, 경구용 ADT 약물의 개발, 장시간 작용하는 주사제 ADT의 도입, 새로운 안드로겐 수용체 억제제의 출현, 디지털 병리 및 진단 도구의 기술 발전 등이 있습니다.
전립선암 환자 수의 증가는 향후 몇 년 동안 안드로겐 제거 요법 시장의 성장을 견인할 것으로 예상됩니다. 전립선암은 남성 생식기관의 일부이자 정액을 분비하는 전립선에서 발생합니다. 이러한 사례의 증가는 주로 수명 연장에 따른 것으로, 노화로 인해 이 암의 발병 위험이 크게 증가하기 때문입니다. 안드로겐 제거 요법(ADT)은 종양의 성장을 촉진하는 안드로겐 농도를 낮추어 효과를 발휘하는 중요한 치료법입니다. 일반적으로 진행성 또는 전이성 전립선암에 사용되며, 질병의 진행을 지연시킵니다. 예를 들어, 2025년 1월 영국 전립선암협회(Prostate Cancer UK)는 영국에서 전립선암 진단 건수가 2022년 50,751건에서 2023년 55,033건으로 증가하여 연간 발병 건수가 눈에 띄게 증가하고 있다고 보고했습니다. 따라서 전립선암 환자 증가로 인해 안드로겐 제거 요법 시장이 성장하고 있습니다.
안드로겐 제거 요법 시장의 주요 기업들은 진행성 전립선암의 예후를 개선하기 위해 병용요법을 포함한 첨단 치료법 개발에 주력하고 있습니다. 병용요법은 화학요법과 병행하여 호르몬 요법 등 여러 가지 치료를 병행하여 효과를 높이고 병의 진행을 늦추는 것입니다. 예를 들어, 바이엘은 2022년 8월 미국 식품의약국으로부터 전이성 호르몬 민감성 전립선암(mHSPC) 치료제로 다롤타미드와 도세탁셀의 병용요법을 승인받았습니다. 새로 승인된 이 병용요법은 암이 퍼졌지만 호르몬 요법에 반응하는 환자의 생존율을 개선하고 질병의 진행을 늦추는 것을 목표로 하고 있습니다. 경구용 약물인 달로타미드는 안드로겐 수용체에 특이적으로 강하게 결합하여 그 활성을 억제함으로써 전립선암 세포의 증식과 전이를 억제합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 안드로겐 제거 요법 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 안드로겐 제거 요법 시장 : 성장률 분석
세계의 안드로겐 제거 요법 시장 실적 : 규모와 성장, 2019-2024
세계의 안드로겐 제거 요법 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 안드로겐 제거 요법 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 안드로겐 제거 요법 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
약
수술
기타 유형
세계의 안드로겐 제거 요법 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
주사제
경구
세계의 안드로겐 제거 요법 시장 : 환자 인구통계별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
40-60세 남성
61-75세 남성
75세 이상 남성
세계의 안드로겐 제거 요법 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
전립선암
기타 용도
세계의 안드로겐 제거 요법 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
기타 최종사용자
세계의 안드로겐 제거 요법 시장 : 하위 세분화 약 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
LHRH 작용제
LHRH 길항제
항안드로겐
CYP17 억제제
스테로이드성 항안드로겐
비스테로이드성 항안드로겐
에스트로겐 기반 치료법
병용요법
세계의 안드로겐 제거 요법 시장 : 하위 세분화 수술 종류, 실적과 예측, 2019-2024, 2024-2029F, 2034F
양측 정소 적출술
피막하 정소 적출술
단순 거세술
세계의 안드로겐 제거 요법 시장 : 하위 세분화 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
방사성의약품 요법
유전자 치료
면역요법
표적요법
냉동요법
고강도 초점식 초음파(HIFU)
제7장 지역별·국가별 분석
세계의 안드로겐 제거 요법 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 안드로겐 제거 요법 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
안드로겐 제거 요법 시장 : 경쟁 구도
안드로겐 제거 요법 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
AstraZeneca PLC
Novartis AG
Astellas Pharma Inc.
Ipsen S.A.
Dr. Reddy's Laboratories Ltd.
Orion Corporation
Arvinas Inc.
Ferring Pharmaceuticals SA
Tolmar Pharmaceuticals Inc.
Besins Healthcare S.A.
Veru Inc.
Kintor Pharmaceutical Limited
Foresee Pharmaceuticals Co. Ltd.
Verity Pharmaceuticals Inc.
Lawley Pharmaceuticals Pty Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
안드로겐 제거 요법 시장 2029 : 새로운 기회를 제공하는 국가
안드로겐 제거 요법 시장 2029 : 새로운 기회를 제공하는 부문
안드로겐 제거 요법 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Androgen deprivation therapy is a treatment approach aimed at lowering or inhibiting the activity of male hormones in the body to restrict the growth of hormone-dependent cells. These hormones are vital for many physiological functions, and reducing their levels can have a significant impact on cellular behavior and biological processes.
The primary forms of androgen deprivation therapy include medication, surgery, and other methods. Medication-based ADT uses drugs to decrease or block androgen production. These drugs can be administered through various methods, such as injections or oral intake, and are prescribed to different patient groups, including men aged 40-60, 61-75, and those over 75. This therapy is primarily applied in the treatment of prostate cancer and other conditions, and is utilized by healthcare providers such as hospitals and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The androgen deprivation therapy market research report is one of a series of new reports from The Business Research Company that provides androgen deprivation therapy market statistics, including androgen deprivation therapy industry global market size, regional shares, competitors with a androgen deprivation therapy market share, detailed androgen deprivation therapy market segments, market trends and opportunities, and any further data you may need to thrive in the androgen deprivation therapy industry. This androgen deprivation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The androgen deprivation therapy market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be linked to the increasing global incidence of prostate cancer, an expanding aging male population, a high rate of cancer recurrence, enhanced survival rates promoting prolonged treatment, and heightened awareness of early prostate cancer screening.
The androgen deprivation therapy market size is expected to see strong growth in the next few years. It will grow to $10.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth expected in the forecast period is driven by greater use of combination therapies in cancer treatment, a rising number of hormone-sensitive cancer cases, increased diagnosis of both localized and advanced prostate cancer, broader application of ADT for hormonal conditions beyond oncology, and a growing patient preference for non-invasive treatments. Key trends during this time include improvements in depot formulations and delivery systems, the development of oral ADT medications, the introduction of long-acting injectable ADT, the emergence of new androgen receptor inhibitors, and technological progress in digital pathology and diagnostic tools.
The rising number of prostate cancer cases is expected to drive the growth of the androgen deprivation therapy market in the coming years. Prostate cancer starts in the prostate gland, which is part of the male reproductive system and produces seminal fluid. The increase in cases is primarily due to longer lifespans, as aging significantly raises the risk of developing this cancer. Androgen deprivation therapy (ADT) is a key treatment option that works by reducing androgen levels, which fuel tumor growth. It is commonly used in advanced or metastatic prostate cancer to slow disease progression. For example, in January 2025, Prostate Cancer UK reported that prostate cancer diagnoses in England rose from 50,751 cases in 2022 to 55,033 cases in 2023, showing a noticeable increase in annual incidence. Therefore, the growing number of prostate cancer cases is boosting the androgen deprivation therapy market.
Leading companies in the androgen deprivation therapy market are focused on developing advanced treatments, including combination therapies, to improve outcomes in advanced prostate cancer. Combination therapy uses multiple treatments, such as hormone therapy alongside chemotherapy, to increase effectiveness and delay disease progression. For instance, in August 2022, Bayer AG received approval from the U.S. Food and Drug Administration for darolutamide combined with docetaxel to treat metastatic hormone-sensitive prostate cancer (mHSPC). This newly approved combination therapy aims to improve survival rates and delay disease advancement in patients whose cancer has spread but still responds to hormone therapy. Darolutamide, an oral drug, uniquely binds tightly to androgen receptors, blocking their activity and helping to inhibit prostate cancer cell growth and spread.
In February 2025, Tempus, a U.S.-based health technology company, partnered with Artera to introduce ArteraAI Prostate Test, an advanced prostate cancer risk assessment tool. This collaboration uses artificial intelligence to improve cancer prognosis accuracy and support better medical decision-making. The ArteraAI digital pathology test, recognized in the NCCN guidelines, helps identify patients with intermediate localized prostate cancer who are more likely to benefit from short-term androgen deprivation therapy. Artera is a U.S.-based digital health company.
Major players in the androgen deprivation therapy market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Astellas Pharma Inc., Ipsen S.A., Dr. Reddy's Laboratories Ltd., Orion Corporation, Arvinas Inc., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Verity Pharmaceuticals Inc., and Lawley Pharmaceuticals Pty Ltd.
North America was the largest region in the androgen deprivation therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in androgen deprivation therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the androgen deprivation therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The androgen deprivation therapy market consists of revenues earned by entities by providing services such as hormonal assessment, monitoring services, telehealth consultations, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The androgen deprivation therapy market also includes sales of hormone monitoring test kits, implantable hormone delivery systems, topical hormone regulation products, and patient monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Androgen Deprivation Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on androgen deprivation therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for androgen deprivation therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The androgen deprivation therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Medicine; Surgery; Other Types
2) By Route Of Administration: Injectable; Oral
3) By Patient Demographics: Men Aged 40-60; Men Aged 61-75; Men Above 75
4) By Application: Prostate Cancer; Other Applications
5) By End-User: Hospitals; Specialty Clinics; Other End-Users
3. Androgen Deprivation Therapy Market Trends And Strategies
4. Androgen Deprivation Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Androgen Deprivation Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Androgen Deprivation Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Androgen Deprivation Therapy Market Growth Rate Analysis
5.4. Global Androgen Deprivation Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Androgen Deprivation Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Androgen Deprivation Therapy Total Addressable Market (TAM)
6.1. Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medicine
Surgery
Other Types
6.2. Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Oral
6.3. Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Men Aged 40-60
Men Aged 61-75
Men Above 75
6.4. Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostate Cancer
Other Applications
6.5. Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.6. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
LHRH Agonists
LHRH Antagonists
Anti-Androgens
CYP17 Inhibitors
Steroidal Anti-Androgens
Non-Steroidal Anti-Androgens
Estrogen-Based Therapies
Combination Therapies
6.7. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bilateral Orchiectomy
Subcapsular Orchiectomy
Simple Orchiectomy
6.8. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiopharmaceutical Therapy
Gene Therapy
Immunotherapy
Targeted Therapy
Cryotherapy
High-Intensity Focused Ultrasound (HIFU)
7. Androgen Deprivation Therapy Market Regional And Country Analysis
7.1. Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Androgen Deprivation Therapy Market
9.1. China Androgen Deprivation Therapy Market Overview
9.2. China Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Androgen Deprivation Therapy Market
10.1. India Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Androgen Deprivation Therapy Market
11.1. Japan Androgen Deprivation Therapy Market Overview
11.2. Japan Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Androgen Deprivation Therapy Market
12.1. Australia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Androgen Deprivation Therapy Market
13.1. Indonesia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Androgen Deprivation Therapy Market
14.1. South Korea Androgen Deprivation Therapy Market Overview
14.2. South Korea Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Androgen Deprivation Therapy Market
15.1. Western Europe Androgen Deprivation Therapy Market Overview
15.2. Western Europe Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Androgen Deprivation Therapy Market
16.1. UK Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Androgen Deprivation Therapy Market
17.1. Germany Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Androgen Deprivation Therapy Market
18.1. France Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Androgen Deprivation Therapy Market
19.1. Italy Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Androgen Deprivation Therapy Market
20.1. Spain Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Androgen Deprivation Therapy Market
21.1. Eastern Europe Androgen Deprivation Therapy Market Overview
21.2. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Androgen Deprivation Therapy Market
22.1. Russia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Androgen Deprivation Therapy Market
23.1. North America Androgen Deprivation Therapy Market Overview
23.2. North America Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Androgen Deprivation Therapy Market
24.1. USA Androgen Deprivation Therapy Market Overview
24.2. USA Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Androgen Deprivation Therapy Market
26.1. South America Androgen Deprivation Therapy Market Overview
26.2. South America Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Androgen Deprivation Therapy Market
27.1. Brazil Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Androgen Deprivation Therapy Market
28.1. Middle East Androgen Deprivation Therapy Market Overview
28.2. Middle East Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Androgen Deprivation Therapy Market
29.1. Africa Androgen Deprivation Therapy Market Overview
29.2. Africa Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Androgen Deprivation Therapy Market Competitive Landscape And Company Profiles
